Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
level decrease » levels decreased (Expand Search), teer decrease (Expand Search), level disease (Expand Search)
Showing 1,761 - 1,780 results of 36,050 for search '(( significant decrease decrease ) OR ( significance ((level decrease) OR (level increased)) ))', query time: 0.53s Refine Results
  1. 1761
    Participants’ characteristics.

    Participants’ characteristics. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1762
    Sources of infection.

    Sources of infection. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1763
    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
    Save to List
    Saved in:
  4. 1764
    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
    Save to List
    Saved in:
  5. 1765
    Absolute and relative ischaemic heart disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile.

    Absolute and relative ischaemic heart disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1766
    Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile.

    Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1767
    Absolute and relative hypertensive heart disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile.

    Absolute and relative hypertensive heart disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1768
    The change of disease burden of CRD by sex in Fujian, 1990-2021.

    The change of disease burden of CRD by sex in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1769
    The change of disease burden of CRD by age groups in Fujian, 1990-2021.

    The change of disease burden of CRD by age groups in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1770
    The change of disease burden of CRD by categories in Fujian, 1990-2021.

    The change of disease burden of CRD by categories in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1771
    The proportion of attributable risk factors of DALYs of CRD in Fujian, 1990-2021.

    The proportion of attributable risk factors of DALYs of CRD in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1772
    The change of attribute risk factors of DALYs in CRD in Fujian, 1990-2021.

    The change of attribute risk factors of DALYs in CRD in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1773
    The change of disease burden of CRD in different region, 1990-2021.

    The change of disease burden of CRD in different region, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1774
    PRISMA flow chart of the screening process.

    PRISMA flow chart of the screening process. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1775
    Forest plot of liver function tests.

    Forest plot of liver function tests. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1776
    Subgroup analysis of BUN based on pump type.

    Subgroup analysis of BUN based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1777
    Subgroup analysis of ICU Stay based on pump type.

    Subgroup analysis of ICU Stay based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1778
    Subgroup analysis of eGFR based on pump type.

    Subgroup analysis of eGFR based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1779
    GRADE evidence profile.

    GRADE evidence profile. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1780
    Characteristics of included studies.

    Characteristics of included studies. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: